Contact us
Please enter your contact details and the Mindpeak team will be in touch.
Book a Demo
Select a date and slot that works for you.
FAQ
Essential definitions for AI, pathology, and regulatory frameworks
Mindpeak focuses on scalable Frontier Model AI built for real-world deployment in regulated environments. Our emphasis is on validation, reproducibility and long-term integration rather than experimental or isolated tools.
Mindpeak prioritizes diverse data curation, cross-site validation and continuous monitoring to support responsible and generalisable AI deployment across clinical environments.
Mindpeak supports secure deployment models and complies with industry-standard data protection and IT security requirements
Mindpeak integrates with established digital pathology infrastructures and supports scalable deployment across laboratory networks and pharmaceutical partnerships.
No. Mindpeak software integrates into established digital pathology systems without disrupting routine clinical practice.
peakFrontier operates across multiplex immunofluorescence, immunohistochemistry and H&E, enabling consistent analysis across discovery, translational research and clinical development workflows.
Mindpeak develops applied AI solutions for digital pathology and precision medicine. Our technology strengthens reproducibility and confidence in tissue-based biomarker assessment across clinical diagnostics and pharmaceutical drug development.
peakFrontier is Mindpeak’s foundational AI architecture. It analyses digital pathology images, including multiplex immunofluorescence, immunohistochemistry and H&E, and converts complex tissue information into structured, quantitative outputs suitable for regulated clinical and research use.
Mindpeak’s peakFrontier AI architecture powers a portfolio of specialised applications designed for clinical and pharmaceutical use:
- peakDiscover – Extracts tissue and cellular features to characterise the tumour microenvironment and identify biomarker signatures
- peakDeploy – Enables scalable deployment of AI tissue biomarker solutions across laboratory networks
- peakAcademy – An AI-native training platform supporting standardised, reproducible biomarker assessment
- peakPredict – A predictive AI ecosystem designed to support the analysis of tissue-based features in relation to treatment response and clinical outcomes
Each solution draws from the same validated underlying architecture, ensuring consistency across discovery, development and clinical implementation.
No. Mindpeak’s AI is designed to support pathologists, not replace them. Our systems function as clinical decision support tools and act as added insurance in complex or high-volume environments. Final diagnostic responsibility remains with the clinician.
Yes. Mindpeak offers CE-IVD certified diagnostic products and operates under an ISO 13485 certified quality management system.
Depending on the product and region, Mindpeak solutions are available as research use only or as CE-IVD certified diagnostic tools. Regulatory status is clearly defined for each product.
Mindpeak solutions undergo structured validation prior to deployment and are evaluated across multiple clinical sites. Performance is continuously monitored in real-world environments to ensure reliability and reproducibility.
Mindpeak operates within regulated clinical environments and maintains a formal quality management system. Governance, documentation and post-deployment monitoring are integral to our approach to AI in healthcare.
Mindpeak’s AI supports quantitative biomarker assessment, companion diagnostic algorithm development and reproducible analysis across multi-site clinical trials. By reducing variability in tissue-based assessment, our technology strengthens confidence in patient stratification and endpoint evaluation.
Our AI applies consistent quantitative analysis across laboratories and clinical sites, helping to reduce inter-observer variability and standardise biomarker interpretation in global studies.